01 1Ajanta Pharma Limited
01 1VORICONAZOLE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-23
Pay. Date : 2023-09-13
DMF Number : 38332
Submission : 2023-05-30
Status : Active
Type : II
20
Ajanta Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VORICONAZOLE USP, with a corresponding US DMF Number 38332.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 23, 2023, and payment made on September 13, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
